近年来,由于新的有效药物的出现,慢性淋巴细胞白血病(CLL)的标准治疗已经取得了相当大的进展.然而,CLL的大部分数据来自西方人群,从亚洲人口的角度对CLL的管理进行了有限的研究和指导。该共识指南旨在了解治疗挑战,并为亚洲人口和其他具有类似社会经济状况的国家的CLL提出适当的管理方法。以下建议基于专家的共识和广泛的文献综述,有助于亚洲统一的患者护理。
In recent years, considerable progress has been made in the standard treatment for chronic lymphocytic leukaemia (CLL) due to the availability of new potent drugs. However, the majority of data on CLL were derived from Western populations, with limited studies and
guidelines on the management of CLL from an Asian population perspective. This
consensus guideline aims to understand treatment challenges and suggest appropriate management approaches for CLL in the Asian population and other countries with a similar socio-economic profile. The following recommendations are based on a
consensus by experts and an extensive literature review and contribute towards uniform patient care in Asia.